347 related articles for article (PubMed ID: 31619668)
41. Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease.
Kawakami K; Takeshita A; Furushima K; Miyajima M; Hatamura I; Kuro-O M; Furuta Y; Sakaguchi K
Sci Rep; 2017 Jan; 7():40534. PubMed ID: 28094278
[TBL] [Abstract][Full Text] [Related]
42. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
Kawata T; Imanishi Y; Kobayashi K; Kenko T; Wada M; Ishimura E; Miki T; Nagano N; Inaba M; Arnold A; Nishizawa Y
Eur J Endocrinol; 2005 Oct; 153(4):587-94. PubMed ID: 16189180
[TBL] [Abstract][Full Text] [Related]
43. Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics.
Nagano N; Nemeth EF
J Pharmacol Sci; 2005 Mar; 97(3):355-60. PubMed ID: 15781990
[TBL] [Abstract][Full Text] [Related]
44. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.
Indridason OS; Heath H; Khosla S; Yohay DA; Quarles LD
Kidney Int; 1996 Nov; 50(5):1663-71. PubMed ID: 8914034
[TBL] [Abstract][Full Text] [Related]
45. Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia.
Fan Y; Liu W; Bi R; Densmore MJ; Sato T; Mannstadt M; Yuan Q; Zhou X; Olauson H; Larsson TE; Toka HR; Pollak MR; Brown EM; Lanske B
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3749-E3758. PubMed ID: 29618612
[TBL] [Abstract][Full Text] [Related]
46. Calcium sensing receptor and renal mineral ion transport.
Rainone F; Arcidiacono T; Terranegra A; Aloia A; Dogliotti E; Mingione A; Spotti D; Francucci CM; Soldati L; Vezzoli G
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):8-12. PubMed ID: 21985973
[TBL] [Abstract][Full Text] [Related]
47. Physiology and pathophysiology of the calcium-sensing receptor in the kidney.
Riccardi D; Brown EM
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F485-99. PubMed ID: 19923405
[TBL] [Abstract][Full Text] [Related]
48. [MiR-301a-5p modulates parathyroid hormone secretion in secondary hyperparathyroidism possibly by regulating calcium-sensing receptor].
Liu L; Qian L; Li P; Li J; Huang S; Yi W; Liu S; Wu W
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1363-1370. PubMed ID: 37712273
[TBL] [Abstract][Full Text] [Related]
49. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney disease.
Quarles LD
Kidney Int Suppl; 2005 Jul; (96):S24-8. PubMed ID: 15954947
[TBL] [Abstract][Full Text] [Related]
50. Nutritional secondary hyperparathyroidism in rabbits.
Bas S; Bas A; López I; Estepa JC; Rodríguez M; Aguilera-Tejero E
Domest Anim Endocrinol; 2005 May; 28(4):380-90. PubMed ID: 15826773
[TBL] [Abstract][Full Text] [Related]
51. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
[TBL] [Abstract][Full Text] [Related]
52. Parathyroid hormone (PTH) secretion, PTH mRNA and calcium-sensing receptor mRNA expression in equine parathyroid cells, and effects of interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha on equine parathyroid cell function.
Toribio RE; Kohn CW; Capen CC; Rosol TJ
J Mol Endocrinol; 2003 Dec; 31(3):609-20. PubMed ID: 14664720
[TBL] [Abstract][Full Text] [Related]
53. Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport.
Ba J; Brown D; Friedman PA
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1233-43. PubMed ID: 12952858
[TBL] [Abstract][Full Text] [Related]
54. High parathyroid hormone concentration in tenofovir-treated patients are due to inhibition of calcium-sensing receptor activity.
Mingione A; Maruca K; Chiappori F; Pivari F; Brasacchio C; Quirino T; Merelli I; Soldati L; Bonfanti P; Mora S
Biomed Pharmacother; 2018 Jan; 97():969-974. PubMed ID: 29136775
[TBL] [Abstract][Full Text] [Related]
55. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
Lee HJ; Seo UH; Kim WY; Woo SU; Lee JB
J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms of secondary hyperparathyroidism.
Silver J; Kilav R; Naveh-Many T
Am J Physiol Renal Physiol; 2002 Sep; 283(3):F367-76. PubMed ID: 12167586
[TBL] [Abstract][Full Text] [Related]
57. Increased parathyroid expression of klotho in uremic rats.
Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
[TBL] [Abstract][Full Text] [Related]
58. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
Ito H; Kinugasa E
Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
[TBL] [Abstract][Full Text] [Related]
59. A mathematical model of calcium and phosphorus metabolism in two forms of hyperparathyroidism.
Raposo JF; Pires A; Yokota H; Ferreira HG
Endocrine; 2012 Apr; 41(2):309-19. PubMed ID: 21874319
[TBL] [Abstract][Full Text] [Related]
60. Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.
Habibullah M; Porter JA; Kluger N; Ranki A; Krohn KJE; Brandi ML; Brown EM; Weetman AP; Kemp EH
J Immunol; 2018 Dec; 201(11):3175-3183. PubMed ID: 30381479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
